- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ALK-genmutation in China
I alt 34611 resultater
-
Shandong UniversityFudan University; Chinese Nutrition SocietySuspenderetSund og rask | GEN1 genmutationKina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eli Lilly and Company; Genentech, Inc.; Kazia... og andre samarbejdspartnereRekrutteringMetastatisk malignt fast neoplasma | Metastatisk malign neoplasma i hjernen | NTRK familie genmutation | CDK-genmutation | PI3K-genmutation | ROS1 genmutation | KRAS G12C mutationForenede Stater
-
Fujian Cancer HospitalUkendt
-
Sun Yat-sen UniversityRekrutteringIkke-småcellet lungekræft (NSCLC) | EGFR-TKI resistent mutation | EGFR-TKI Sensibiliserende mutation | Somatisk mutation | KimlinjemutationerKina
-
QED Therapeutics, Inc.Helsinn Healthcare SAAfsluttetFGFR2-genmutation | Avanceret cholangiocarcinomKorea, Republikken, Forenede Stater, Belgien, Spanien, Taiwan, Kina, Det Forenede Kongerige, Frankrig, Canada, Tyskland, Thailand, Italien, Portugal, Australien, Puerto Rico
-
Southwest Oncology GroupNational Cancer Institute (NCI)AfsluttetBRCA1 genmutation | BRCA2 genmutation | Tilbagevendende planocellulært lungekarcinom | Stadie IV Planocellulært lungekarcinom AJCC v7 | BRIP1 genmutation | PALB2-genmutation | ATM-genmutation | ATR-genmutation | CHEK2 genmutation | NBN-genmutation | RAD51 genmutation | CHEK1 genmutation | FANCA genmutation | FANCD2 genmutation og andre forholdForenede Stater, Canada
-
Affiliated Hospital to Academy of Military Medical...RekrutteringEndoskopi | Mitokondriel DNA-mutationKina
-
Guangdong Provincial People's HospitalShanghai Junshi Bioscience Co., Ltd.RekrutteringIkke-småcellet lungekræft | BRAF V600 Mutation | MET Amplifikation | MET Exon 14 Skipping Mutation | RET driver mutation | Erb-B2-receptortyrosinkinase Exon 20-mutationKina
-
First Affiliated Hospital of Chongqing Medical...Ikke rekrutterer endnuKræft | Positron emissionstomografi | Stimulator af interferon-genKina
-
Boehringer IngelheimAfsluttet
-
Ruijin HospitalRekrutteringP53 Mutation | Myeloid malignitet | MDS | AmlKina
-
Hubei Biological Medicine Industrial Technology...UkendtAvancerede solide tumorer | HRD | BRCA mutationKina
-
Zhongnan HospitalAktiv, ikke rekrutterendeFarmakokinetisk | Abirateronacetat | Plasma koncentration | Gen polymorfisme | Metabolisk analyseKina
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.UkendtSolid tumor | HER-2-genamplifikation | HER2 genmutation | HER-2 Protein OverekspressionKina
-
The Affiliated Hospital of Xuzhou Medical UniversityRekrutteringType 2 diabetes mellitus | Genetiske mutationer | Gen-polymorfismer | Modtagelighed, genetiskKina
-
Jiangsu Simcere Pharmaceutical Co., Ltd.RekrutteringAvancerede eller metastatiske solide tumorer med NTRK, ROS1 eller ALK genfusionKina
-
SUNHO(China)BioPharmaceutical CO., Ltd.Rekruttering
-
AnHeart Therapeutics Inc.RekrutteringCholangiocarcinom med IDH1-mutation | Solide tumorer med IDH1-mutationKina
-
BeBetter Med IncXiangya Hospital of Central South UniversityRekrutteringAvanceret eller metastatisk solid tumor | KRAS G12C mutationKina
-
Tianjin Medical University Second HospitalRekrutteringSolid tumor | FGF-receptorgenmutation | FGF amplifikation | FGF-receptorgenfamilieomlægning | FGF-receptorgentranslokationKina
-
Hunan Province Tumor HospitalIkke rekrutterer endnuLunge Adenocarcinom | ALK-genmutation | ImmunterapiKina
-
Second Xiangya Hospital of Central South UniversityThe First Affiliated Hospital of Nanchang University; Xiangya Hospital... og andre samarbejdspartnereRekrutteringLungekræft, ikke-småcellet | Cirkulerende tumor-DNA | EGFR-genmutation | EGFR-TKI resistent mutation | Primær modstandKina
-
Boehringer IngelheimRekrutteringSolid Tumor, KRAS-mutationForenede Stater, Taiwan, Japan
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.UkendtBrystkræft Metastatisk | BRCA 1 genmutation | BRCA 2 genmutationKina
-
The First Affiliated Hospital of Guangzhou Medical...Ukendt
-
Nanfang Hospital of Southern Medical UniversityRekrutteringForskelligt gen mellem forskellige TKI's effektKina
-
Lei LiAfsluttetEpitelial ovariecancer | BRCA1 mutation | BRCA2 mutation | Homolog rekombinationsmangel | Prognose | Kinesisk | Homologe rekombinationsgenerKina
-
The First Affiliated Hospital of Soochow UniversityUkendt
-
Boehringer IngelheimAfsluttet
-
Jiangsu Province Centers for Disease Control and...Bejing Vigoo Biological Co., LTDAfsluttetSystembiologi | Tidlig Gene | EV71-vaccineKina
-
Sun Yat-sen UniversityIkke rekrutterer endnuNSCLC | BRAF V600 Mutation | MET Exon 14 mutationKina
-
Yongchang ZhangRekrutteringHER2 Insertion Mutation Positiv Advanced NSCLCKina
-
Second Affiliated Hospital, School of Medicine,...RekrutteringRisikofaktorer | Gen polymorfisme | Alvorlig paradentoseKina
-
Sir Run Run Shaw HospitalAfsluttet
-
Xueding WangSun Yat-sen UniversityUkendtGastrointestinale stromale tumorer | Somatisk mutation | Plasma koncentration | Germline mutationKina
-
Blueprint Medicines CorporationAktiv, ikke rekrutterendeNeoplasmer | Neoplasmer efter histologisk type | Lungesygdomme | Neoplasmer efter sted | Adenocarcinom | Karcinom | Karcinom, ikke-småcellet lunge | Neoplasmer i luftvejene | Karcinom, bronkogent | Bronkiale neoplasmer | Metastatisk lungekræft | Antineoplastiske midler | Hjernemetastaser | Lungeneoplasma ondartet | EGFR-aktiverende... og andre forholdForenede Stater, Canada, Korea, Republikken, Japan, Taiwan
-
The First Hospital of Jilin UniversityRekruttering
-
Tianjin Medical University Cancer Institute and...RekrutteringIkke-småcellet lungekræft | EGFR-aktiverende mutation | EGFR-TKI resistent mutation | CellecyklusdereguleringKina
-
RenJi HospitalPeking University First Hospital; Shanghai Zhongshan Hospital; First Affiliated... og andre samarbejdspartnereRekrutteringNyrekræft | Nyrecellekarcinom | ALK-genmutation | MET-genmutation | HLRCC | Nyretumorhistologi | Kutan leiomyom | BAP1 Tumor Predisposition Syndrome | VHL syndrom | Birt-Hogg-Dube syndrom | Familiær nyrekræft | FLCN-genmutation | FH-genmutation | Kutan Leiomyomata Med Uterine LeiomyomataKina
-
Shanghai Changzheng HospitalUkendtIldfast kræft | Arsen trioxid | p53 Mutationer | Uoverskuelig kræftKina
-
Shanghai Jiatan Pharmatech Co., LtdRekrutteringGastrisk type adenocarcinom (GAS) med STK11-mutationKina
-
Henan Cancer HospitalUkendtAvanceret NSCLC med EGFR-mutationKina
-
Peking Union Medical CollegeUkendtBryst Neoplasma Kvinde | Mutation | TerapeutikKina
-
Li JunminUkendtAkut myeloid leukæmi | P53 MutationKina
-
Peking Union Medical CollegeUkendtBrystkræft | HER2 genmutationKina
-
Zhejiang Cancer HospitalAfsluttetBrystkræft | PI3K/AKT/mTOR Pathway Mutation | EverolimusKina
-
wang, jianxiangRekrutteringAkut myeloid leukæmi | CEBPA dobbelt mutationKina
-
First Affiliated Hospital of Jinan UniversityRuijin HospitalRekrutteringAkut myeloid leukæmi | Myelodysplastiske syndromer | P53 Mutation | Myeloid malignitet | Temperaturfølsom p53-mutation | NatriumstibogluconatKina
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.Aktiv, ikke rekrutterendeBrystkræft Metastatisk | BRCA 1 genmutation | BRCA 2 genmutationItalien, Spanien, Forenede Stater, Tjekkiet, Rumænien, Frankrig, Korea, Republikken, Det Forenede Kongerige, Ungarn, Japan, Peru, Polen, Den Russiske Føderation, Kalkun, Kina, Taiwan, Bulgarien, Schweiz, Mexico
-
Ascletis Pharmaceuticals Co., Ltd.RekrutteringHIV-infektioner | HIV-1-infektion | PD-L1 genmutationKina